Certara’s latest narrative update reflects a subtly recalibrated fair value of about $13.21 per share, shaped by more tempered revenue growth assumptions and a slightly lower discount rate that signals marginally reduced perceived risk….
How Recent Developments Are Rewriting the Story for Certara’s Biosimulation Leadership
